KATE DEVARNEY, PH.D.
Corporate Board Profile
Tech Score:
0
/100
← Back to All Directors
TITAN PHARMACEUTICALS INC
Filing Date
Source Excerpt
2020-11-02
/s/ Kate Devarney, Ph.D. Kate Devarney, PhD., President and Chief Operating Officer
Data sourced from SEC filings. Last updated: 2026-02-03